Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Article Type
- Case Reports1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Med Pediatr Oncol1
Search Results
Sort by
- BookRamin Kordi, Nicola Maffulli, Randall R. Wroble, W. Angus Wallace, editors.Digital Access Springer 2009
- ArticleChessells JM, Cornbleet M.Med Pediatr Oncol. 1979;6(4):359-65.Thirty-four children with acute lymphoblastic leukaemia (ALL) in relapse or resistant to initial induction received combination chemotherapy with prednisolone, vincristine, l-asparaginase, and daunorubicin. L-asparaginase was given subcutaneously on alternate days for four weeks and was well tolerated. A complete remission was achieved in 96% of children in relapse and in five out of six children resistant to induction. Remission was achieved without hospitalisation in over 60% of patients. The median duration of subsequent remission was only 13 weeks, but six out of eight children receiving a second course of the drug combination achieved a further remission. We conclude that prolonged l-asparaginase therapy in combination with an anthracycline might well be used in initial or consolidation therapy for childhood ALL.